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Summary In the Helsingborg Declaration the continuum of care consisting of pre-, intra- and
posthospital organization of stroke services combined with evaluation of outcome measures and
dedicated quality assessments was considered as key for best outcome. Despite the evidence
of such measures there are still striking disparities in organized stroke care all over Europe.
Aim of this paper is to describe current concepts used for process optimization in stroke care
and to evaluate if methodologies used in industry provide additional beneﬁt in order to address
this issue.
We describe the transfer of a commonly accepted industrial maturity model to stroke care
addressing structural, process and outcome quality. Moreover, this tool can be used to compare
different stroke services and provides valuable information for their optimization by transfer-
ring best practices from ‘‘best in class’’ services as well as for prioritization of improvement
measures.
© 2012 Elsevier GmbH.
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The burden of stroke is high due to its high incidence, mor-
tality and morbidity [1—4]. In order to reduce this burden,
the Helsingborg Declaration has postulated the present and
future European goals of stroke care. As a major component
of the chain of care, stroke unit treatment was considered
essential, and was therefore nominated the ‘‘backbone’’ of
integrated stroke services. This is clear scientiﬁc evidence
that outcomes in stroke patients managed in dedicated
stroke units are better than those managed in general
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Open access under CC BY-NC-ND license.edical wards [5]. Within one year, stroke unit care leads
o signiﬁcantly reduced death or poor outcome [6]. As a
ogical consequence, basic requirements were deﬁned for
uccessful stroke unit care, which are multi-professional
eam approach, acute treatment combined with early mobi-
ization and rehabilitation, as well as an exclusive admission
f patients with stroke syndromes to that ward [6]. More-
ver, the continuum of stroke care was considered as the key
or best outcome consisting of prehospital, intrahospital and
osthospital organization of stroke services, also considering
econdary prevention, as well as step down rehabilitation
fter stroke, includingmeasures for evaluation of stroke out-
ome and dedicated quality assessment [5]. However, there
re still striking disparities in organized stroke unit care all
ver Europe [7—10], and no generally accepted deﬁnition
f a stroke unit in terms of state-of-the-art require-
ents of facilities, personal and processes does exist. In
rder to solve this problem, there are constraints in the
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uropean Stroke Organization to deﬁne a terminology and
hared requirements on a European stroke unit (Ringelstein,
ersonal communication). Hospitals should be encouraged
o compete for the best solution, and the most engaged
nes should serve as guides and frontiers for stroke unit
evelopment. In addition, a recent consensus paper [11]
equested to improve and develop the systems of interna-
ional cooperation in stroke research, and to implement key
lements into clinical pathways which are identiﬁed to be
eneﬁcial in stroke treatment. Moreover, it was postulated
o identify and implement standardized clinical and surro-
ate assessments and to accelerate the capacity to address
nmet needs. This could be done by scanning other areas
f science in order to enhance the likelihood of generating
ew ideas and concepts.
In industries the optimization of infrastructure and pro-
esses and the determination of so-called key performance
ndicators in order to proof the efﬁcacy of improvement
easures is standard since many years. By extending the
bove stroke-related requests, the aim of this paper is to
valuate whether concepts can be transferred from indus-
ry to healthcare in order to support optimization processes
n stroke unit care.
ethodology
n a ﬁrst step, current concepts used worldwide for the opti-
ization of stroke treatment were analyzed regarding their
fﬁcacy. Possible reasons for suboptimal results from these
easures were extracted. In a second step, generally avail-
ble methodologies for process optimization used in industry
ere analyzed with respect to their transfer into health-
are systems. In particular, we analyzed which requirements
ave to be met by those methodologies in order to be trans-
erred successfully, how the relevant clinical and scientiﬁc
ontent could be identiﬁed and implemented as basis for
ptimization. We also elaborated how clinical and scientiﬁc
vidence of the content and improvement potentials could
e ensured.
esults
linical guidelines were found to be the most important
ources for optimizing stroke care and have to be obeyed
n all circumstances. This is due to their scientiﬁc and clin-
cal evidence. Some hospitals, however, do not support to
mplement them into clinical routine in an effective matter
eopardizing their impact. Programs monitoring guideline
dherence are addressing this issue but do not provide
nough support for systematic implementation.
Several national certiﬁcation programs are based on
uidelines, but rather assess the structural quality of a
troke service than the process and the improvement of
reatment quality and clinical outcome; although it has been
hown in a recent publication that certiﬁcation efforts can
ead to better clinical outcome [12]. A new certiﬁcation
rogram proposed by the European Stroke Organization will
vercome some of the above mentioned shortages and will
onitor outcome parameters. Guidance for hospitals willing
o improve their processes, however, will still be required
‘
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or a sufﬁcient implementation of clinical guidelines into
outine processes.
The effect of programs measuring quality or performance
ndicators is still under debate [13] and they often focus
oo much on the formal fulﬁllment of requirements like
rescription and dispensation of anticoagulants, or statins
s well as the early rehabilitation assessment, but are not
elpful in deﬁning how to increase the performance level
14]. The underlying processes to ensure the fulﬁllment of
iven requirements and regulations have to be deﬁned and
mplemented by the hospital staff.
Quality management systems like ISO, EFQM and TQM
valuate structures and processes but do not assess the
elated outcome. They were ﬁrst used in industry and trans-
erred to healthcare systems thereafter. The necessity that
n individual organization has to deﬁne its own quality
oals, as well as the processes to achieve them, could be
onsidered as a weakness. Moreover, those programs are
ddressing entire hospitals rather than speciﬁc diseases or
unctional units.
Pure industrial process optimization programs are
ddressing processes without considering best practices
rom other organizations. After deﬁning their own quality
oals, the processes to achieve them have to be developed
y the organization itself.
Finally, process consulting is helpful in order to solve
ndividual problems, and best practice transfer is the basis
f this type of optimization. Most consulting projects are
ery long lasting, however, and put a high burden of the
rganization regarding human resources.
According to our experience, all above-mentioned pro-
rams are addressing relevant parts of clinical process
ptimization in stroke care. None of them provides a holis-
ic solution, however. Reviewing the literature, Donabedian
15] has deﬁned three different qualities in medical care
escribing the basis for optimization in stroke care. The
tructural quality is covered by guideline adherence. In this
ontext it is important that the guidelines are deﬁned by
he medical societies and based on clinical and scientiﬁc
vidence. However, the guidelines have to be implemented
nto clinical processes resulting in a positive impact on pro-
ess quality. By combining both efforts, the quality of care
s expected to increase but this effect has to be monitored
n order the proof outcome quality.
In order to address these three qualities, a methodol-
gy for process optimization in stroke care has to include
ll the relevant clinical guidelines and to reﬂect the orga-
izational structure which is deﬁned by speciﬁc guidelines.
oreover, such a methodology has to have the capability
o support optimization of clinical processes addressed by
anagement consulting tools. Additionally, transfer of best
ractices will be helpful in achieving this goal. Our focus
hould be on support processes as well, which contributes
n improving the process quality, e.g. providing optimized
maging infrastructure. An essential part is also to measure
uality parameters thus addressing structural, procedural
nd outcome performance indicators.
Keeping all these requirements in mind, so called‘process maturity models’’ seem to best meet our needs.
hey are generally accepted in software industry or aero-
autics. The calculation of a provider’s maturity level which
s an integral part allows even benchmarking between
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hospitals and can be used to deﬁne best practices and to
facilitate their transfer. Thereafter, Process improvements
can be derived from those best practices best practices.
Combining this methodology with intelligent approaches for
simulation, prioritization between different improvement
measures becomes possible.
Because industrial maturity models are based on a virtual
best practice combination composed of real-world practice
elements from various organizations, the question arises
how this principle can be applied to healthcare systems.
In our clinical maturity model named ‘‘Act on Stroke’’,
we implemented all relevant clinical guidelines, as well
as latest results in stroke research based on clinical and
scientiﬁc evidence. We performed best practice visits in
institutions well known for their excellent stroke service and
included experience from more than 400 consulting projects
in healthcare. In the end, our data resulted in a clinical
maturity model addressing optimized stroke care.
Best practice visits and pilot projects in hospitals with
experienced department heads in stroke care were per-
formed and provided further promising results which again
were introduced into the methodology. Indeed, heads of the
departments certiﬁed that all relevant strengths and weak-
nesses of their services have been identiﬁed by using this
clinical maturity model. Proposals for process improvements
have also been helpful to them. Meanwhile, the ﬁrst regular
projects have been carried out successfully, and the results
are currently in preparation for publication.
Discussion
For more than 40 years, maturity models have been helpful
in software industry in order to improve processes and, as a
consequence, leading to better outcomes. This principle has
been used for the optimization of clinical processes, as well.
Healthcare is dealing with human beings, however, has and
the applicability of industrial processes had to be discussed
carefully.
The content for the deﬁnition of the virtual best prac-
tice is of clinical and scientiﬁc relevance, and it has to be
speciﬁed who deﬁnes it. From our point of view this should
be done as a joint venture by experienced stroke physicians
in cooperation with specialists experienced in process opti-
mization. Care has to be taken that the patient’s needs and
the adherence to clinical guidelines are the most important
and that the maturity level is respecting this. A not yet fully
solved problem is how to deal with improvement measures
to processes or requirements not yet based on clinical evi-
dence. It has been shown [16,17] that improvement of key
measures lead to better outcome even if they are as such
not based on large randomized trials. The fact that some
requirements are based on clinical evidence while others are
not, has to be met by the particular methodology of ‘‘Act on
Stroke’’ and a solution for this issue has been implemented.
In contrast to the linear nature of industrial processes,
processes in healthcare are more complex and can be inﬂu-
enced by hard to control parameters. For this reason, it is
not always possible to directly assess the impact of a single
optimization measure, because a given factor inﬂuencing a
certain process does not do so in different hospitals. As a
consequence, the efﬁcacy of our model has to be proven
[for stroke diagnosis and treatment 75
rst in pilot projects, in particular with respect to clinical
utcomes.
The authors have developed a clinical maturity model
roviding answers to the above mentioned questions. They
arried out several pilot projects for proof of principle
nd with the intention of individual process optimiza-
ion. A detailed description of the methodology and the
ncouraging results of the ﬁrst projects are currently under
valuation and will be published in a separate paper.
onclusion
ndustry can provide useful tools for supporting the opti-
ization of quality of care and outcome in stroke treatment.
his can be achieved by a standardized and unbiased assess-
ent of hospital infrastructure, improved processes of
troke care and comparison of outcome performance from
‘best in class’’ services.
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